✨ Free AI Report
Precipio, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Precipio, Inc.
Research Preview

Precipio, Inc.: Business Overview, Financials & Competitive Analysis

Precipio is a healthcare biotechnology company that provides cancer diagnostic products, reagents, and services in the United States, with a focus on diagnostic blood cancer testing services. The company leverages adv...

Analyst-debate audio for Precipio, Inc.

AskCyborg analysts argue the bull and bear cases for Precipio, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Precipio, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
4/ 10Mixed

Cyborg Score thesis

Early-stage cancer diagnostics company with promising technology but unprofitable operations and limited scale, requiring...

Read the full analyst-debate transcript →
Industry Healthcare Biotechnology - Cancer Diagnostics & Laboratory Medicine
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Precipio, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Precipio, Inc. Overview

Pro stress-test →

Precipio is a healthcare biotechnology company that provides cancer diagnostic products, reagents, and services in the United States, with a focus on diagnostic blood cancer testing services. The company leverages advanced molecular and digital imaging technologies to improve accuracy and speed in hematologic disease diagnosis.

Strategic Profile

Pro stress-test →

Precipio develops precision diagnostic solutions integrating digital morphology, immunophenotyping, and molecular testing to improve diagnosis of leukemia and related blood disorders, designed to enhance accuracy and speed of laboratory workflows. The company offers IV-Cell, a proprietary cell culture media, and HemeScreen, a suite of genetic diagnostic panels.

Competitive Landscape

Pro stress-test →

Precipio competes in the blood cancer diagnostics market against established players like T2 Biosystems, Biodesix, and ENDRA Life Sciences. The company differentiates through proprietary culture media (IV-Cell) and rapid genetic diagnostic panels (HemeScreen), targeting laboratory efficiency improvements and diagnostic accuracy in hematologic malignancies.

Industry Context

Precipio, Inc. operates in Healthcare Biotechnology - Cancer Diagnostics & Laboratory Medicine.

Key facts

Founded: 1997 · Headquarters: New Haven, Connecticut, US · Revenue: Growth of 27% YoY · Market cap: $32.7M-$41.6M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Precipio, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Precipio, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

T2 Biosystems platformsRapid molecular diagnostic systems for sepsis and other infectious diseases→Biodesix diagnostic testsProtein-based blood tests for cancer and chronic disease management→ENDRA imaging solutionsThermal imaging diagnostic technology for tissue characterization→

Compare Precipio, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Precipio, Inc. operates in Healthcare Biotechnology - Cancer Diagnostics & Laboratory Medicine. See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare Biotechnology - Cancer Diagnostics & Laboratory Medicine research →
NEW · MCP server

Ask your AI assistant about Precipio, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Precipio, Inc. and its top competitor on Cyborg Score”
“What did Precipio, Inc. do this quarter?”
“Is Precipio, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Precipio, Inc. do?+
Precipio is a healthcare biotechnology company that provides cancer diagnostic products, reagents, and services in the United States, with a focus on diagnostic blood cancer testing services. The company leverages adv...
What is Precipio, Inc.'s Cyborg Score?+
Precipio, Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Precipio, Inc.'s main competitors?+
Named competitors include T2 Biosystems platforms, Biodesix diagnostic tests, ENDRA imaging solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full Precipio, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Precipio, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Precipio, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9National Bank of Pakistan9RENK Group AG9Lumentum Holdings Inc.9First Abu Dhabi Bank9The Travelers Companies, Inc.9BAE Systems plc9Arista Networks9KLA Corporation9Hermès International S.A.8Enerjisa Enerji A.Ş.8Emirates Central Cooling Systems Corporation8WALLIX Group8StealthGas Inc.8SofWave Medical Ltd.8Himalaya Shipping Ltd.8Bannerman Energy Ltd8Sembcorp Salalah Power & Water Company8MilDef Group